Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 1

Optimal timing for antihypertensive dosing: focus on valsartan

Total article views   HTML views PDF downloads Totals
6,575 Dovepress* 6,575+ 1,996 8,571
Totals 6,575 1,996 8,571
*Since 15 March 2007
+Since July 2016

View citations on Google Scholar